Fingerprint
Dive into the research topics of 'Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases
Phillip A. Bonney, Joshua A. Santucci, Adrian J. Maurer, Michael E. Sughrue, Rene Y. McNall-Knapp, James D. Battiste
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations